VBI Vaccines
VBIV
#10030
Rank
ยฃ1.47 M
Marketcap
ยฃ0.05156
Share price
0.00%
Change (1 day)
-90.41%
Change (1 year)

Revenue for VBI Vaccines (VBIV)

Revenue in 2024 (TTM): ยฃ7.63 Million

According to VBI Vaccines 's latest financial reports the company's current revenue (TTM ) is ยฃ7.43 Million. In 2023 the company made a revenue of ยฃ6.81 Million an increase over the revenue in the year 2022 that were of ยฃ0.89 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for VBI Vaccines from 1998 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ7.63 M12%
2023 ยฃ6.81 M661.97%
2022 ยฃ0.89 M91.32%
2021 ยฃ0.46 M-39.94%
2020 ยฃ0.77 M-54.04%
2019 ยฃ1.69 M-35.92%
2018 ยฃ2.64 M312.96%
2017 ยฃ0.64 M44.11%
2016 ยฃ0.44 M600.16%
2015 ยฃ0.06 M
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A
2000 ยฃ0.04 M-64.67%
1999 ยฃ0.12 M6.59%
1998 ยฃ0.11 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.17 M-97.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.63 B 8,424.07%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.02 M 7.97%๐Ÿ‡บ๐Ÿ‡ธ USA